Sparsentan after approval: Defining the treatment boundary in FSGS without nephrotic syndrome

Nefrología · Elsevier

Аннотация

Publication date: November 2026 Source: Nefrología, Volume 46, Issue 9 Author(s): Lucas Maciel de Almeida Corrêa, Luiggi Kevin Virgino Brandão, Yan Roberth Delmiro Silva, Camilla Cristina Silva Fernandes, Isabela Malerba Pinheiro, Éverton Victor Belmiro da Silva, Gabriela Wander Fossati, Maria Clara do Nascimento Meneses, Sicilia Lins Peixoto Arruda

Читать у издателя →

Похожие статьи